Next Ventures today announced the close of its second fund, Next Ventures II (“Fund II”), at $60 million. Fund II will continue the firm’s strategy of investing in entrepreneurs advancing whole-person health.
Building on its inaugural fund launched in 2019, Next Ventures has partnered with category-defining companies that are enabling millions to live healthier, more capable lives. These portfolio companies are expanding access to care, extending healthspan, and redefining how health care is delivered in the U.S.
The healthcare sector is undergoing profound transformation as consumers assume greater ownership of their health and AI emerges as a powerful driver of efficiency, intelligence, and personalization across the care continuum. Against this backdrop, the opportunity set for investment is expanding significantly.
With institutional backing from the Oregon Growth Board and a strategic partnership with Oregon Health & Science University, Fund II strengthens Next Ventures’ ability to partner with entrepreneurs who share its vision of a proactive and interconnected healthcare system.
To date, Fund II has invested in five companies: BranchLab, WTHN, Cofertility, Ramble, and a care delivery company in stealth.
For more on the Next Ventures’ perspective on the space, see here.
Next Ventures is an early-stage venture capital firm dedicated to founders defining whole-person health. The firm sees the future of healthcare as a proactive and interconnected ecosystem—one that empowers individuals, extends healthspan, and redefines models of care with greater efficiency and intelligence. For more information, visit www.nextventures.com.
jordan@nextventures.com
Next Ventures